Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Dr. Reddy's Laboratories announces the launch of Pyrimethamine Tablets USP, 25 mg, first-wave generic version of Daraprim® in the U.S. Market

Posted On: 2020-03-20 13:23:57

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent and first-wave generic version of Daraprim® (pyrimethamine) Tablets, approved by the U.S. Food and Drug Administration (USFDA). This product is the only ABrated generic version Daraprim® (pyrimethamine) Tablets approved by the USFDA.

"I am extremely proud of our teams at Dr. Reddy's and Cerovene whose hard work and efforts, coupled with significant financial investments over the past seven years journey, have helped bring this important product to market," says, Marc Kikuchi, Chief Executive Officer, North America Generics, Dr.Reddy's Laboratories. "Our team's relentless pursuit of this difficult-to-procure reference drug and its active pharmaceutical ingredients-in addition to recent actions from the USFDA - will benefit patients by providing a more affordable alternative to the brand." According to Kikuchi, the company is offering this product at a substantial discount compared with the current brand price.

"The achievements of the Cerovene team to develop, file and manufacture Pyrimethamine Tablets is a testament to our dedication and commitment to be able to provide this product to the patients who need it most. We are pleased to collaborate with Dr. Reddy's as our commercial partner to make this important drug available to patients in the U.S.," says, Ray DiFalco, Co-Founder and Vice President of Operations for Cerovene. "This approval represents our continued commitment to develop and provide patients with greater choices and lower-cost alternatives for prescription pharmaceuticals."

In a recent press release regarding the approval of this product, the USFDA reiterated its commitment to improve "the efficiency of the generic drug development, review and approval process, as well as closing loopholes that allow brand-name drug companies to delay the generic competition." The approval and launch of Dr. Reddy's Pyrimethamine is a testament to the agency's actions, providing generic drug companies the opportunity to compete fairly in the marketplace.

Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

The Daraprim® (pyrimethamine) brand had U.S. sales of approximately $10 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health*.

Dr. Reddy's Pyrimethamine Tablets USP, are available in 25 mg dose in bottle count sizes of 30 and 100.

Shares of DR.REDDY's LABORATORIES LTD. was last trading in BSE at Rs.2622.75 as compared to the previous close of Rs. 2667.75. The total number of shares traded during the day was 23401 in over 4624 trades.

The stock hit an intraday high of Rs. 2680.85 and intraday low of 2497.6. The net turnover during the day was Rs. 60429854.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

DCB Bank announces revised Marginal Cost of Funds based Lending Rate

DCB Bank revises External Benchmark Linked Rate

CRISIL reaffirms ratings of Bhagwati Autocast Ltd

H.G. Infra Engineering Limited Supports India's Fight Against COVID-19

ICRA downgrades rating of PNB Housing Finance Limited's NCDs and Tier II bonds

Persistent Systems contributing Rs. 25 Crores ($3.3M) in support of COVID-19 efforts globally

CARE has reaffirmed issuer rating of Ashiana Housing Ltd

IDBI Bank updates on Moody's rating

CARE reaffirms rating of DCB Bank Limited

Sunteck Realty Limited's 'AA-' long-term and 'A1+' short-term ratings reaffirmed by CARE

PTC India Financial Services Ltd updates on credit ratings

Parsvnath Developers Ltd announces interest holiday to all its customers for 3 months

APM Terminals Pipavav offers Free Container Storage service at the port

NMDC revises iron ore price from April 4, 2020

Blue Dart ensures continuity of essential supply chain for the nation during COVID-19 outbreak

Nestlé India Extends Its Commitment To India's Fight Against COVID-19

Mr. Sunil D'Souza joins as Managing Director & CEO of Tata Consumer Products Ltd

TCPL Packaging Limited update on non-disposal undertaking by Promoter Group Companies

Moody's downgrades AXIS Bank outlook to Negative

HDFC Bank advances increases to Rs. 9,930 billion as of March 31, 2020

M&M Holds a Special Board Meeting to Review Investment in SsangYong Motor Company

Moody's affirms deposit ratings of ICICI Bank

GMR Infrastructure Limited updates on tariff order

Lasa pledge to contribute for fight against COVID 19

ICRA reaffirms ratings of HLE Glascoat Limited

Dhampur Sugar Mills Ltd starts hand sanitizers production at Asmoli unit

IEX assures the nation of 24X7 access to facilitate uninterrupted power supply

A kind initiative by UNO Minda group to fight against Corona

NMDC contributes Rs.60 Lakh to Ballari District Administration to support the fight against COVID-19

Ind-Ra revises long term issuer rating of HCL Infosystems Ltd

Oriental Aromatics Ltd starts partial production at Bareilly

Vedanta doubles its contribution to Rs. 201 crores to fight COVID-19

UPL contributes Rs. 75 Crore to PM-CARES Fund

IEX announces performance for March 2020

MOIL contributes Rs 45 crore in PM Cares Fund

KEI Industries Ltd. extends support to ISKCON Delhi to feed more than 2 lakh homeless daily

Ajanta Pharma commits Rs. 6 crore to fight COVID-19 pandemic

The Ramco Cements Ltd contributes Rs. 2.50 crores to Tamil Nadu CM Relief Fund

IDBI BANK LTD board to consider rupee bond borrowings limit for FY 2020-21

Raymond Ltd allots 18,54,599 shares

OnMobile Global Ltd board to consider buyback on Apr 9, 2020

National Fertilizers Ltd registers highest-ever Fertilizer sale in 2019-20

ITC Salutes its Frontline Warriors in the fight against Corona

Sportking India Ltd starts operations at Bathinda unit

Cyient to Partner with Hitachi Rail to Accelerate Signaling Technology Deployment

Sunil Healthcare Ltd board approves funding requirements

Bajaj Auto reports 10% YoY drop in sales during March 2020

Lupin's Aurangabad Facility Receives EIR from U.S. FDA

NTPC Ltd commissions Unit-2 of 660 MW of Khargone Super Thermal Power Station

AU Small Finance Bank Ltd announces completion of term by part-time chairman







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019